Source: Annual Congress 2001 - Inhalation devices and technique
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Newman, J. Richards, P. Hirst, I. Abramowitz, A. Nolting (Nottingham, United Kingdom; Jersey City, United States Of America). Lung targeting of flunisolide is enhanced when delivered as an extra fine HFA aerosol with a built-in spacer. Eur Respir J 2001; 16: Suppl. 31, 540

Member's Comments

No comment yet.

Related content which might interest you: In vitro comparison of output and particle size distribution of budesonide from metered-dose inhaler with three spacer devices during pediatric tidal breathing Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005 In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation. Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children Source: Eur Respir J 2007; 29: 299-306 Year: 2007 Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019 Assessment of relative potency of salbutamol administered via a metered-dose inhaler plus spacer or via a dry-powder inhaler in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 209s Year: 2006 A submicron suspension of budesonide improves the mass of ICS delivered during early nebulization Source: Eur Respir J 2006; 28: Suppl. 50, 712s Year: 2006 In vitro lung deposition of fluticasone propionate/formoterol (FP/FORM) pressurized metered dose inhaler (pMDI) with different inhalation profiles Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Comparison of aerosol delivery from two inhaler technique-guidance devices. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer. Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019 Cost-effectiveness of fluticasone compared with beclomethasone extra fine aerosol Source: Eur Respir J 2001; 18: Suppl. 33, 49s Year: 2001 Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 In vitro analysis of two formulations of fluticasone/ salmeterol pMDI for delivered dose uniformity and aerodynamic particle size distribution Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 A breath-actuated nebulizer provides greatly reduced fugitive aerosol emissions compared with a continuously operating nebulizer Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 Systemic activity of inhaled beclomethasone dipropionate HFA: a comparison of volume spacers Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 The in vitro fine particle dose with Symbicort Rapihaler pMDI is similar using either NebuChamber or AeroChamber Plus valved holding chamber spacer devices Source: Eur Respir J 2005; 26: Suppl. 49, 504s Year: 2005 Assessment of the suitability of filters for use in clinical studies with an HFA fluticasone propionate pressurized metered dose inhaler (pMDI) and a valved holding chamber (VHC) Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011 Short term growth and hypopituitary-adrenal axis function in asthmatic children treated with inhaled beclomethasone dipropionate HFA with a spacer Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005 In vitro comparison of aerosol characteristics of HFA albuterol (salbutamol) pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Reusable soft mist inhaler: maintaining aerosol performance Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018